Paul Cremer, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Kiniksa(MODEST), Cardiol Therapeutucs(MODEST), Monte Rosa Therapeutics(MODEST), Ventyx Biosciences(MODEST), Boston Scientific(MODEST), Pfizer(MODEST)

View Full Disclosure